Intra-Tumoral Lipopolysaccharide Immunotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Intra-Tumoral Lipopolysaccharide Immunotherapy, covering 2024-12-10 to 2024-12-10. Get the full timeline:
Most recent: Clinical Trial Update: Feasibility Study of Intra-Tumoral Lipopolysaccharide Immunotherapy for Intra-Abdominal [Phase 1]